Skip to main content

Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab.

Publication ,  Journal Article
Agarwal, A; Barrow, W; Selim, MA; Nicholas, MW
Published in: JAMA Dermatol
July 1, 2016

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA Dermatol

DOI

EISSN

2168-6084

Publication Date

July 1, 2016

Volume

152

Issue

7

Start / End Page

842 / 844

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Sweet Syndrome
  • Subcutaneous Tissue
  • Recurrence
  • Middle Aged
  • Male
  • Immunohistochemistry
  • Humans
  • Follow-Up Studies
  • Drug Administration Schedule
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Agarwal, A., Barrow, W., Selim, M. A., & Nicholas, M. W. (2016). Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab. JAMA Dermatol, 152(7), 842–844. https://doi.org/10.1001/jamadermatol.2016.0503
Agarwal, Ashwin, Willis Barrow, M Angelica Selim, and Matilda W. Nicholas. “Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab.JAMA Dermatol 152, no. 7 (July 1, 2016): 842–44. https://doi.org/10.1001/jamadermatol.2016.0503.
Agarwal A, Barrow W, Selim MA, Nicholas MW. Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab. JAMA Dermatol. 2016 Jul 1;152(7):842–4.
Agarwal, Ashwin, et al. “Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab.JAMA Dermatol, vol. 152, no. 7, July 2016, pp. 842–44. Pubmed, doi:10.1001/jamadermatol.2016.0503.
Agarwal A, Barrow W, Selim MA, Nicholas MW. Refractory Subcutaneous Sweet Syndrome Treated With Adalimumab. JAMA Dermatol. 2016 Jul 1;152(7):842–844.

Published In

JAMA Dermatol

DOI

EISSN

2168-6084

Publication Date

July 1, 2016

Volume

152

Issue

7

Start / End Page

842 / 844

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Sweet Syndrome
  • Subcutaneous Tissue
  • Recurrence
  • Middle Aged
  • Male
  • Immunohistochemistry
  • Humans
  • Follow-Up Studies
  • Drug Administration Schedule